期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | GENETICS IN MEDICINE LetPub Score 8.8
50 ratings
Rate
Reputation 9.9 Influence 8.2 Speed 7.1 | ||||||||||||||||
期刊簡稱 | GENET MED | ||||||||||||||||
ISSN | 1098-3600 | ||||||||||||||||
E-ISSN | 1530-0366 | ||||||||||||||||
h-index | 111 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 6.10%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | https://www.journals.elsevier.com/genetics-in-medicine | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/genetmed/default.aspx | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | ELSEVIER | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | USA | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1998 | ||||||||||||||||
每年文章數 | 164每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 65.65% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1098-3600%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) 來自Elsevier的數據: Average 1.3 weeks Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Moderate 來自Elsevier的數據: 26% | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[GENETICS IN MEDICINE] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:17:01 評論於 Abstract primarily describes the purpose of the paper, the methods used, the results obtained, and their significance. The abstract should include only the most important 4 or 5 points, results, or implications(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 08:47:06 評論於 Be clear, accurate, concise, highlight the key points, and present the information in a clear and easy-to-understand manner. Try to use short sentences to avoid ambiguity in meaning but avoid repetition(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 08:56:59 評論於 What are the key points to writing an abstract?(0) 讚! | 深渊兴业 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 18:36:40 評論於 How detailed should the abstract be?(0) 讚! | 平原文波 |
作者: 紫霞俊誉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-04 22:48:54 評論於 What happens after "decision in process"?(0) 讚! | 紫霞俊誉 |
作者: 慈悲尚昆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-07-24 08:59:56 評論於 It has been four days and the decision is still in process. Is it still in the hands of the editor?(0) 讚! | 慈悲尚昆 |
作者: 弘大小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-05-29 09:18:25 評論於 It's been four days. Decision still in process. Is it still in the editor's hands?(0) 讚! | 弘大小仙女 |
作者: 东风静姝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-09-15 22:25:03 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: Article on somatic cell mutations. Submitted on July 5, 2017. Received first-round comments on August 18. Two reviewers, both with relatively positive evaluations, raised many questions. No additional experiments required, mainly needed revisions in the expression throughout the manuscript. Revised on August 21. Received final comments on September 13. Feels like this journal is more interested in new discoveries of key genes related to human diseases or articles that may potentially change genetic counseling strategies and testing methods selection principles(0) 讚! | 东风静姝 |
作者: 东风静姝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-08-01 09:51:14 評論於 Can anyone share their experience in getting an article published? Thank you~(0) 讚! | 东风静姝 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 23:48:23 評論於 Rise is just a word, welcome the rise. Judging from this momentum, it is expected to break through 10 points in the future! I am in Anhui and can send an article, satisfied(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 12:08:36 評論於 Will it go up again next year?(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us